Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.21.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2019 10,587,632        
Beginning balance, amount at Dec. 31, 2019 $ 10,587 $ 38,508,825 $ (10,970) $ (25,880,586) $ 12,627,856
Issuance of common stock under a Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC, net of commissions and fees, shares 33,903        
Issuance of common stock under a Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC, net of commissions and fees, amount $ 34 526,109     526,143
Issuance of common stock to non-employee directors pursuant to vested restricted stock units, shares 1,288        
Issuance of common stock to non-employee directors pursuant to vested restricted stock units, amount $ 1 (1)     0
Stock-based compensation (non-cash)   338,497     338,497
Offering costs   (2,161)     (2,161)
Net loss (1,090,877) (1,090,877)
Ending balance, shares at Mar. 31, 2020 10,622,823        
Ending balance, amount at Mar. 31, 2020 $ 10,622 39,371,269 (15,011) (26,971,463) 12,395,417
Beginning balance, shares at Dec. 31, 2020 11,453,465        
Beginning balance, amount at Dec. 31, 2020 $ 11,453 47,873,570 (7,873) (32,185,159) 15,691,991 [1]
Issuance of common stock under a Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC, net of commissions and fees, shares 1,104,047        
Issuance of common stock under a Capital on DemandTM Sales Agreement with JonesTrading Institutional Services LLC, net of commissions and fees, amount $ 1,104 10,924,208     10,925,312
Issuance of common stock to non-employee directors pursuant to vested restricted stock units, shares 3,004        
Issuance of common stock to non-employee directors pursuant to vested restricted stock units, amount $ 3 (3)     0
Issuance of common stock to employees pursuant to vested restricted stock units, net of taxes, shares 6,504        
Issuance of common stock to employees pursuant to vested restricted stock units, net of taxes, amount $ 7 (21,507)     (21,500)
Issuance of common stock upon exercise of stock options, shares 2,913        
Issuance of common stock upon exercise of stock options, amount $ 3 17,475     17,478
Stock-based compensation (non-cash)   368,232     368,232
Net loss (1,884,019) (1,884,019)
Accumulated other comprehensive (loss) income     2,774   2,774
Ending balance, shares at Mar. 31, 2021 12,569,933        
Ending balance, amount at Mar. 31, 2021 $ 12,570 $ 59,161,975 $ (5,099) $ (34,069,178) $ 25,100,268
[1] Derived from the Company's audited consolidated financial statements.